(Q36392706)

13 August 2017

1 reference

title

Hyponatremia and heart failure--treatment considerations (English)

1 reference

13 August 2017

0 references

1 reference

Domenic A Sica

1

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

published in

Congestive Heart Failure

1 reference

13 August 2017

volume

12

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

55-60

1 reference

Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Usefulness of spironolactone in a specialized heart failure clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Differential pharmacokinetics of lithium in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Neurohormonal activation in congestive heart failure and the role of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Vasopressin antagonism in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

The therapeutic potential of vasopressin receptor antagonists in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Vasopressin antagonism: a future treatment option in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Vasopressin: a new target for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

Drug-Induced Lithium Toxicity in the Elderly: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04844.X

10.1111/J.1527-5299.2006.04844.X

21 January 2018

Identifiers

DOI

1 reference

release_3fwizjiejndkpii5macqkbw6ba

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3fwizjiejndkpii5macqkbw6ba

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference